200 related articles for article (PubMed ID: 23830530)
1. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial.
Hui D; Xu A; Frisbee-Hume S; Chisholm G; Morgado M; Reddy S; Bruera E
J Pain Symptom Manage; 2014 Feb; 47(2):209-17. PubMed ID: 23830530
[TBL] [Abstract][Full Text] [Related]
2. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Kilgore K; Frisbee-Hume S; Park M; Liu D; Balachandran DD; Bruera E
J Pain Symptom Manage; 2017 Dec; 54(6):798-805. PubMed ID: 28803087
[TBL] [Abstract][Full Text] [Related]
3. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E
J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Hernandez F; Larsson L; Liu D; Kilgore K; Naberhuis J; Virgilio A; Reddy S; Reddy A; Dalal S; Haider A; Driver L; Azhar A; Dev R; Bruera E
J Pain Symptom Manage; 2019 Oct; 58(4):605-613. PubMed ID: 31276809
[TBL] [Abstract][Full Text] [Related]
5. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer.
Pinna MÁ; Bruera E; Moralo MJ; Correas MÁ; Vargas RM
Am J Hosp Palliat Care; 2015 May; 32(3):298-304. PubMed ID: 24259406
[TBL] [Abstract][Full Text] [Related]
6. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
7. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
Rauck R; Reynolds L; Geach J; Bull J; Stearns L; Scherlis M; Parikh N; Dillaha L
Curr Med Res Opin; 2012 May; 28(5):859-70. PubMed ID: 22480131
[TBL] [Abstract][Full Text] [Related]
10. Does nebulized fentanyl relieve dyspnea during exercise in healthy man?
Kotrach HG; Bourbeau J; Jensen D
J Appl Physiol (1985); 2015 Jun; 118(11):1406-14. PubMed ID: 26031762
[TBL] [Abstract][Full Text] [Related]
11. EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.
Simon ST; Kloke M; Alt-Epping B; Gärtner J; Hellmich M; Hein R; Piel M; Cornely OA; Nauck F; Voltz R
J Pain Symptom Manage; 2016 Nov; 52(5):617-625. PubMed ID: 27693898
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
[TBL] [Abstract][Full Text] [Related]
13. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
[TBL] [Abstract][Full Text] [Related]
14. Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl.
Milne KM; Ibrahim-Masthan M; Scheeren RE; James MD; Phillips DB; Moran-Mendoza O; Ja N; O'Donnell DE
Respir Physiol Neurobiol; 2020 Nov; 282():103511. PubMed ID: 32758677
[TBL] [Abstract][Full Text] [Related]
15. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled feasibility randomized trial?
Sanz Rubiales Á; del Valle ML
J Pain Symptom Manage; 2014 Jul; 48(1):e4-5. PubMed ID: 24819084
[No Abstract] [Full Text] [Related]
17. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.
Shimoyama N; Gomyo I; Teramoto O; Kojima K; Higuchi H; Yukitoshi N; Ohta E; Shimoyama M
Jpn J Clin Oncol; 2015 Feb; 45(2):189-96. PubMed ID: 25378647
[TBL] [Abstract][Full Text] [Related]
19. High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial.
Hui D; Morgado M; Chisholm G; Withers L; Nguyen Q; Finch C; Frisbee-Hume S; Bruera E
J Pain Symptom Manage; 2013 Oct; 46(4):463-73. PubMed ID: 23739633
[TBL] [Abstract][Full Text] [Related]
20. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
Barnes H; McDonald J; Smallwood N; Manser R
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
